AAV-CREERT2 (AAV-serotype 8) AAV (AAV8-CreERT2)
Kwaliteit
ISO Gecertificeerd
Levering
24-48 uur
Technische Specificaties
A mutated form of estrogen ligand-binding domain (ERT2) that binds to synthetic antagonists (such as tamoxifen or its derivative 4-hydroxy-tamoxifen) but not to circulating estrogens was fused to the Cre recombinase (Cre) to create the CreERT2, which requires the presence of tamoxifen for Cre recombinase activity. Therefore it makes possible to induce the recombination in cells with tamoxifen.This AAV-8 virus expresses CreERT2 under a CMV promoter.
AAV-CReERT2 (AAV serotype 8) AAV
41106621
3822190000
Pre-Made
Dry Ice
-80C
12 Months
AAV8-CreERT2
AAV8
AAV2
Recombinant AAV
CMV (ubiquitous)
PBS/5% Glycerol
1x10^13 GC/ml
Beschrijving
A mutated form of estrogen ligand-binding domain (ERT2) that binds to synthetic antagonists (such as tamoxifen or its derivative 4-hydroxy-tamoxifen) but not to
Specificaties
Recent bekeken producten
0.22μm Syringe Filter
F1021
13mm, 50 / Pk, 500 / Cs
Erdafitinib
B2458-25
25 mg
TRPM4-IN-2
BA7024-1
1 mg
TRPM4-IN-1
HY-122605-01
5 mg
Anti-RAVV Envelope glycoprotein/GP Recombinant Antibody (SAA2752)
VK160013-01
50 µg
Recombinant BoHV-1 Envelope glycoprotein E
DRA167-01
50 µg
GelRed® Agarose LE
#41029-5G
1x 5 g
50 ml Disposable Serological Pipette
CPP00050
100/CS
